U.S. officials have argued that Europe should be paying more for drugs to help lower Americans' prices. But whether they have ...

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

A small but powerful nugget is buried in the text of the House budget reconciliation bill released this week: A clause that ...

Pope Francis was hospitalized for more than five weeks. A pneumonia riddled both of his lungs, and his doctors thought he was ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

Access to care could be affected, following HHS indication that it will not enforce updates adopted in 2024 to the mental ...

Hospitals pay provider taxes, helping states spend more on Medicaid and increase the amounts paid by the federal government.

Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

The lines between fact, science, and uncertainty are increasingly blurred. Things once treated as dogma are being questioned.

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...

UnitedHealth Group CEO Andrew Witty abruptly stepped down from the health insurance and care conglomerate on Tuesday, citing ...

Biotech investment firm RA Capital has laid off staff at its internal startup incubator, highlighting the instability among ...